JP2005508857A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005508857A5 JP2005508857A5 JP2002591038A JP2002591038A JP2005508857A5 JP 2005508857 A5 JP2005508857 A5 JP 2005508857A5 JP 2002591038 A JP2002591038 A JP 2002591038A JP 2002591038 A JP2002591038 A JP 2002591038A JP 2005508857 A5 JP2005508857 A5 JP 2005508857A5
- Authority
- JP
- Japan
- Prior art keywords
- cyano
- guanidine
- pyridyl
- cancer
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US29292801P | 2001-05-24 | 2001-05-24 | |
| PCT/DK2002/000351 WO2002094322A2 (en) | 2001-05-24 | 2002-05-24 | Combination medicament for treatment of neoplastic diseases containing cyanoguanidine ikk inhibitors and a second anti-neoplastic drug |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005508857A JP2005508857A (ja) | 2005-04-07 |
| JP2005508857A5 true JP2005508857A5 (https=) | 2006-01-05 |
Family
ID=23126850
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002591038A Withdrawn JP2005508857A (ja) | 2001-05-24 | 2002-05-24 | 新生物疾患処置用の薬剤組み合わせ |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US20030045515A1 (https=) |
| EP (1) | EP1411984B1 (https=) |
| JP (1) | JP2005508857A (https=) |
| KR (1) | KR20040007607A (https=) |
| CN (1) | CN1516600A (https=) |
| AT (1) | ATE394100T1 (https=) |
| AU (1) | AU2002316795B2 (https=) |
| BR (1) | BR0209936A (https=) |
| CA (1) | CA2449442A1 (https=) |
| CZ (1) | CZ20033189A3 (https=) |
| DE (1) | DE60226446D1 (https=) |
| HU (1) | HUP0400024A3 (https=) |
| IL (1) | IL158821A0 (https=) |
| MX (1) | MXPA03010691A (https=) |
| PL (1) | PL366462A1 (https=) |
| RU (1) | RU2291710C2 (https=) |
| WO (1) | WO2002094322A2 (https=) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2485351C (en) * | 2002-05-17 | 2011-12-06 | Leo Pharma A/S | Cyanoguanidine prodrugs |
| US7253193B2 (en) * | 2002-05-17 | 2007-08-07 | Leo Pharma A/S | Cyanoguanidine prodrugs |
| CA2484671A1 (en) * | 2002-05-17 | 2003-11-27 | Leo Pharma A/S | Cyanoguanidine prodrugs |
| JP2006512313A (ja) | 2002-10-31 | 2006-04-13 | アムジェン インコーポレイテッド | 抗炎症剤 |
| US20050101576A1 (en) * | 2003-11-06 | 2005-05-12 | Novacea, Inc. | Methods of using vitamin D compounds in the treatment of myelodysplastic syndromes |
| WO2004047673A2 (en) * | 2002-11-21 | 2004-06-10 | Novacea, Inc. | Treatment of liver disease with active vitamin d compounds |
| US20050075341A1 (en) * | 2003-07-17 | 2005-04-07 | Pharmacia Corporation | Compositions of a cyclooxygenase-2 selective inhibitor and an IKK inhibitor for the treatment of ischemic mediated central nervous system disorders or injury |
| AR050253A1 (es) | 2004-06-24 | 2006-10-11 | Smithkline Beecham Corp | Compuesto derivado de indazol carboxamida, composicion que lo comprende y su uso para la preparacion de un medicamento |
| TW200626142A (en) | 2004-09-21 | 2006-08-01 | Glaxo Group Ltd | Chemical compounds |
| JP5189367B2 (ja) * | 2004-12-22 | 2013-04-24 | レオ ファーマ アクティーゼルスカブ | 新規シアノグアニジン化合物 |
| US8063071B2 (en) | 2007-10-31 | 2011-11-22 | GlaxoSmithKline, LLC | Chemical compounds |
| NZ563687A (en) | 2005-06-30 | 2011-07-29 | Smithkline Beecham Corp | 3-[1-(ethylsulfonyl)-4-piperidinyl]-5-[2-(1-methylethyl)-2,3-dihydro-1H-isoindol-5-yl]-1H-indole-7-carboxamide for inhibiting IKK2 (aka IKKbeta) |
| JP2009502996A (ja) * | 2005-08-04 | 2009-01-29 | バイエル・ヘルスケア・アクチェンゲゼルシャフト | ＩＫＫ−β阻害剤との組合せ |
| PE20081889A1 (es) | 2007-03-23 | 2009-03-05 | Smithkline Beecham Corp | Indol carboxamidas como inhibidores de ikk2 |
| US11969501B2 (en) | 2008-04-21 | 2024-04-30 | Dompé Farmaceutici S.P.A. | Auris formulations for treating otic diseases and conditions |
| KR20130097813A (ko) | 2008-04-21 | 2013-09-03 | 오토노미, 인코포레이티드 | 귀 질환 및 병태를 치료하기 위한 귀 조제물 |
| EP2394649A4 (en) * | 2009-02-06 | 2012-08-15 | Tianjin Hemay Bio Tech Co Ltd | PHARMACEUTICAL COMPOSITIONS CONTAINING PYRIDYL-CYANOGUANIDINES, PREPARATION METHODS AND USES THEREOF |
| WO2010102968A1 (en) | 2009-03-10 | 2010-09-16 | Glaxo Group Limited | Indole derivatives as ikk2 inhibitors |
| CN106243023A (zh) | 2010-09-03 | 2016-12-21 | 福马Tm有限责任公司 | 用于抑制nampt的胍化合物和组合物 |
| CN108779073A (zh) * | 2015-06-23 | 2018-11-09 | 凯斯西储大学 | 用于治疗癌症的组合物和方法 |
| JP7033789B2 (ja) | 2016-06-29 | 2022-03-11 | オトノミー，インク． | トリグリセリド耳用製剤とその使用 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9219472D0 (en) * | 1992-09-15 | 1992-10-28 | Leo Pharm Prod Ltd | Chemical compounds |
| US5919816A (en) * | 1994-11-14 | 1999-07-06 | Bionumerik Pharmaceuticals, Inc. | Formulations and methods of reducing toxicity of antineoplastic agents |
| DE69734405T2 (de) * | 1996-07-15 | 2006-08-03 | Sankyo Co., Ltd. | Verwendung von CS-866 (Olmersartan) zur Herstellung eines Medikaments für die Behandlung von Arteriosklerose |
| GB9711122D0 (en) * | 1997-05-29 | 1997-07-23 | Leo Pharm Prod Ltd | Novel cyanoguanidines |
| GB9711123D0 (en) * | 1997-05-29 | 1997-07-23 | Leo Pharm Prod Ltd | Novel cyanoguanidines |
| GB9711125D0 (en) * | 1997-05-29 | 1997-07-23 | Leo Pharm Prod Ltd | Novel cyanoguanidines |
| GB9711124D0 (en) * | 1997-05-29 | 1997-07-23 | Leo Pharm Prod Ltd | Novel cyanoguanidines |
| GB9711119D0 (en) * | 1997-05-29 | 1997-07-23 | Leo Pharm Prod Ltd | Novel cyanoguanidines |
| AU1494702A (en) * | 2000-11-21 | 2002-06-03 | Leo Pharma As | Cyanoguanidine prodrugs |
-
2002
- 2002-05-21 US US10/151,094 patent/US20030045515A1/en not_active Abandoned
- 2002-05-24 EP EP02745167A patent/EP1411984B1/en not_active Expired - Lifetime
- 2002-05-24 CN CNA028121880A patent/CN1516600A/zh active Pending
- 2002-05-24 CA CA002449442A patent/CA2449442A1/en not_active Abandoned
- 2002-05-24 KR KR10-2003-7015363A patent/KR20040007607A/ko not_active Ceased
- 2002-05-24 CZ CZ20033189A patent/CZ20033189A3/cs unknown
- 2002-05-24 MX MXPA03010691A patent/MXPA03010691A/es unknown
- 2002-05-24 PL PL02366462A patent/PL366462A1/xx not_active Application Discontinuation
- 2002-05-24 WO PCT/DK2002/000351 patent/WO2002094322A2/en not_active Ceased
- 2002-05-24 BR BR0209936-5A patent/BR0209936A/pt not_active IP Right Cessation
- 2002-05-24 IL IL15882102A patent/IL158821A0/xx unknown
- 2002-05-24 AU AU2002316795A patent/AU2002316795B2/en not_active Ceased
- 2002-05-24 DE DE60226446T patent/DE60226446D1/de not_active Expired - Fee Related
- 2002-05-24 JP JP2002591038A patent/JP2005508857A/ja not_active Withdrawn
- 2002-05-24 AT AT02745167T patent/ATE394100T1/de not_active IP Right Cessation
- 2002-05-24 HU HU0400024A patent/HUP0400024A3/hu unknown
- 2002-05-24 RU RU2003137006/15A patent/RU2291710C2/ru not_active IP Right Cessation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2005508857A5 (https=) | ||
| EP4010329B9 (en) | Deuterated compounds for use in the treatment of cancer | |
| EP1450799B2 (en) | Aryl urea compounds in combination with other cytostatic or cytotoxic agents for treating human cancers | |
| RU2003137006A (ru) | Комбинированное лекарственное средство для лечения опухолевых заболеваний | |
| AU2021202619B2 (en) | Multifunctional inhibitors of MEK/PI3K and mTOR/MEK/PI3K biological pathways and therapeutic methods using the same | |
| JP5201995B2 (ja) | ジアザベンゾ［デ］アントラセン−３−オン化合物、及び、ｐａｒｐの阻害方法 | |
| EA032639B1 (ru) | Гидрохлоридные соли n-(цианометил)-4-(2-(4-морфолинофениламино)пиримидин-4-ил)бензамида | |
| CN104968358B (zh) | 涉及粘液素的疾病治疗 | |
| CA2447021A1 (en) | Pyridyl cyanoguanidine compounds | |
| JPWO2020163823A5 (https=) | ||
| WO2019094053A1 (en) | Disulfiram and copper salt dosing regimen | |
| ES3008687T3 (en) | Heterocyclic compounds for use in the treatment of cancer | |
| KR20160106042A (ko) | 암 치료용 약학적 배합물 | |
| CN1511036A (zh) | 包含信号转导抑制剂和埃坡霉素衍生物的联合形式 | |
| CA2485351A1 (en) | Cyanoguanidine prodrugs | |
| US6822001B2 (en) | Combination therapy using pentafluorobenzenesulfonamides and antineoplastic agents | |
| US20200237779A1 (en) | Combination therapy with a bet inhibitor and a bcl-2 inhibitor | |
| JP2025041742A (ja) | 薬学的組合せ | |
| JP2023509191A (ja) | 癌を治療するための組み合わせ療法 | |
| TW201306833A (zh) | 包含康布列塔司他汀（ｃｏｍｂｒｅｔａｓｔａｔｉｎｓ）族衍生物及西妥昔單抗（ｃｅｔｕｘｉｍａｂ）之組合 | |
| JP2010526073A (ja) | 癌または前癌性症状およびその他の症状の治療のためのジヒドロピリジン誘導体 | |
| WO2020234445A1 (en) | Combination therapy with a bet inhibitor and a bcl-2 inhibitor | |
| HK40076656A (en) | Deuterated compounds for use in the treatment of cancer | |
| HK40076656B (en) | Deuterated compounds for use in the treatment of cancer | |
| HK40026061A (en) | Combination therapy with a bet inhibitor and a bcl-2 inhibitor |